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Background: This study evaluated the effect of aminoguanidine on liver of diabetic rats subject to physical
exercises using histological and histochemical techniques.
Methods: The rats used in this study were divided into five groups: sedentary control, sedentary diabetic, trained
diabetic, sedentary diabetic and treated with aminoguanidine, trained diabetic and treated with aminoguanidine.
Results: The results showed no effect of aminoguanidine on the liver tissue, although there was improvement with
exercise training showing cytological, morpho-histological and histochemical alterations in liver cells of animals
from groups trained diabetic and/or treated diabetic compared to those individuals in the sedentary control and
sedentary diabetic. These changes included: hepatocytes hypertrophy, presence and distribution of polysaccharides
in the hepatocytes cytoplasm and, especially, congestion of the liver blood vessels.
Conclusion: Our results suggest that aminoguanidine is not hepatotoxic, when used at dosage of 1 g/L for the
treatment of diabetes complications, and confirmed that the practice of moderate physical exercise assuaged the
damage caused by diabetes without the use of insulin.
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Diabetes mellitus (DM) is a metabolic disorder charac-
terized by lack or deficiency of insulin secretion or even
by the peripheral resistance to it [1]. The insulin defi-
ciency affects the metabolism of carbohydrates, lipids and
proteins resulting in hyperglycemia and glycosuria, re-
sponsible for degenerative diseases of arterial system,
eyes and the brain [1]. In fact, it was considered the fifth
major cause of death in the world [2].
Regular physical activity induces structural and functional
changes which increase the metabolism of the organism [3].
During physical activity several sources of energy are used,
including glycogen from muscles and liver, as well as the
triglycerides stored in the adipose tissue. The main source
of energy used during the first 20 or 30 minutes of physical
exercise of moderate intensity is the glycogen. After this
period, the oxidation of lipids is predominant [3,4].* Correspondence: micm@rc.unesp.br
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reproduction in any medium, provided the orThe physical exercise improves catchment of glucose
by the cells and increases the glycogenesis, promoting,
at the same time, adaptations in the skeletal muscle
which stimulate the increase of the utilization of lipids
[3]. Physical exercises of moderate intensity would be
recommended to improve the metabolic control of dia-
betics, particularly those who are resistant to insulin,
except when there are contraindications [5].
The practice of physical exercises brings visible results,
such as the decrease in the insulin secretion and in-
crease in glucagon secretion, due to the activity of the
sympathetic nervous system, which directly innerves the
Langerhans islets (endocrine portion of the pancreas), via
alpha adrenergic receptors (predominantly) [6].
Thus, the physical exercise would be one of the re-
sponsible factors for the decrease in insulin secretion and
increase in glucagone secretion, exceeding the even the same
metabolic stimuli as glycemia, which would either not be
altered or could be elevated during prolonged exercise [6].
Data from literature demonstrate the occurrence of the
beneficial effects of physical training on DM, either by theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
e Nico et al. Journal of Diabetes & Metabolic Disorders 2013, 12:40 Page 2 of 9
http://www.jdmdonline.com/content/12/1/40increase of sensibility to insulin or by the effect on its
secretion [7].
The process of insulin secretion by pancreatic cells is
modulated by several factors including nutrients, neuro-
transmitters and hormones. The main stimulating factor
for the insulin secretion is the glucose, the only nutrient-
in vitro-which promotes (alone) the release of insulin [8].
The most important effect of insulin in the organism
is to promote the transportation of glucose to the interior
of the cells, in special muscular cells, adipose and hepatic
[8]. The deficiency of insulin can cause, among other con-
sequences, the decrease capability of synthetizing and ac-
cumulating glycogen in the liver [6].
Insulin is a peptide hormone secreted by pancreas, such
hormone favors the storage of substrates and the mainten-
ance of the tissues. In normal levels of glycemia (between
75 and 100 mg/mL) and in the absence of insulin, the
nervous tissue would be the only to use the circulating
glucose in amounts sufficient to the maintenance of its
metabolic needs. The presence of insulin would then be
necessary to ensure the entrance of adequate amounts
of glucose in other cells. Independently of the cause,
the lack of insulin would alter the metabolism of the
glycides, lipids and proteins in the organisms [9].
The occurrence of vascular damages in diabetic individ-
uals would be related to the formation of AGEs (advanced
glycation end products), molecules formed from the
glycation (aminocarbonyl interactions–non-enzymatic
nature) of proteins and lipids consequent from hyper-
glycemia which can attach to the walls of sanguineous
vases [10]. In this sense it is known that aminoguanidine
would be an anti-AGEs agent, being efficient in the ther-
apy against the formation of atherosclerosis plaques in
vases of diabetic rats [11].
Aminoguanidine is an anti-AGE which prevents the
formation of ROS (Reactive Oxygen Species) and lipid
peroxidation in cells which has been shown to be effective
in the therapy against the formation of atherosclerotic
plaques in blood vessels in diabetic rats [11,12]. By binding
to the reactive carbonyl groups Amadori products formed
during the Maillard reaction, avoids thus the formation of
AGEs [13].
Aminoguanidine prevents the formation of AGEs due
to the presence of hydrazine in its chemical structure, which
reacts with glyoxal, methylglyoxal and 3-deoxyglucosone
[14]. In addition to the effects on advanced glycation, the
aminoguanidine acts in a specific way inhibiting the ac-
tivity of the enzyme iNOS (nitric oxide synthase) redu-
cing the nitrosative stress [15].
The liver is a gland, attached to the digestive system,
responsible for the storage and the metabolism of the
nutrients absorbed by the intestines, such as lipids, pro-
teins and carbohydrates, and also for the collection and
transformation of metabolites from several parts of theorganism [16]. According to Hinton and Laurén [17], the
liver is also the organ responsible for the detoxification
of xenobiotic compounds, being essential for their me-
tabolism and excretion.
Considering the information exposed above, this study
aimed to analyze, using cytological, histological and histo-
chemical techniques, fragments of diabetic rats’ livers
subjected to treatment with aminoguanidine and phys-
ical exercises, detecting the potential of the action of
this substance and possible damages that this chemical
would cause to the individuals treated with medications
containing it in their composition.
Material and methods
Animals
Twenty five male albino rats (Wistar) obtained from the
Central Biotery of Universidade Estadual Paulista (Sao Paulo
State University)–UNESP, Campus of Botucatu, SP, Brazil
and weighing between 180 and 200 g, were used. During
the whole experiment, the animals were maintained in
collective plastic boxes (three animals/box) in the Main-
tenance Biotery of the Physical Education Department
of the Bioscience Institute, UNESP, campus of Rio Claro,
SP, Brazil, under controlled conditions (22°C ± 2°C, 50%
of humidity and photo period of 12 h) and received
water and commercial food Purina (Campinas, SP, Brazil)
ad libitum.
Induction to diabetes
The animals induced to diabetes type 1 fasted for 18 hours
and after this period received a single dose (intraperito-
neal) of estreptozotocine (Sigma-Aldrish CO, Saint Louis,
MO, EUA) at the concentration of 60 mg/kg diluted cit-
rate buffer 0.1 M and pH 4.5 [18].
Obtainment of pimagedine (aminoguanidine)
The aminoguanidine (AG) (Sigma-Aldrish CO, Saint Louis,
MO, EUA) was administered via drinking water in solution
of 0.1% (1 g/L) of AG for 8 weeks after the induction of
diabetes [11].
Experimental model
The rats to be studied were divided into five groups: sed-
entary control (C/SD), sedentary diabetic type 1 (DB/SD),
trained diabetic type 1 (DB/TR), sedentary diabetic type 1
and treated with aminoguanidine (DB/SD-AG), trained dia-
betic type 1 and treated with aminoguanidine (DB/TR-AG).
Physical exercise program
The chosen physical training was running on treadmill.
In the first week, the animals were subjected to a period
of adaptation to the treadmill and to the speed which
was progressively increased ranging from 5 (on the first
day) to 10 m/min (on the fifth day). The speed and the
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the animals could remain running for 60 minutes. Only
animals adapted to this activity were chosen and used in
this study.
In the second week the physical training started with
the speed of 10 m/min, increasing progressively according
to the group of animals until reaching the final speed
correspondent to the maximal lactate steady state (MLSS)
anteriorly established for rats. A group of diabetic rats was
specially induced for the determination of the training’s
intensity. The intensity of the treadmill training for dia-
betic type 1 animals was determined through MLSS test.
It is defined as the highest intensity of activity that can be
maintained without the continuous accumulation of blood
lactate, where the aerobic metabolism predominates over
the anaerobic, being an important marker of the aerobic
capacity [19,20]. The blood lactate is an indicator of me-
tabolism transition and authors consider the concentration
of 4,0 mmol/L as a marker of the start of lactate accumula-
tion [21,22]. The animals presented stabilization in the lac-
tate concentration at speeds 10 m/min (3,3 ± 0,3 mmol/L)
and 15 m/min (3,6 ± 0,3 mmol/L). However, increasing
accumulation of lactate was observed at 20 m/min (6,0 ±
1,1 mmol/L). Considering the definition of MLSS we
used the speed of 15 m/min for the physical training,
5 days/week, 60 minutes each session, for 8 weeks, dur-
ing the morning. At the end of the total period of train-
ing, the 12-hour fasting animals rested for 48 hours.
Then the animals were anesthetized with 30 mg/Kg of
intraperitoneal sodium thiopental and a longitudinal in-
cision was made in the abdomen for the collection of
arterial blood sample (7 mL), obtained from the descend-
ing branch of the aorta. The animals were then sacrificed
by exsanguination following anesthesia. This study was
approved by the Ethics Committee of Animal Experimen-
tation CEEA/UNICAMP Biology Institute (IB) (protocol
number 1753–1).Methods
Histology
After being sacrificed, the rats were placed on wax plates
for dissection. Fragments of the liver were removed with
the use of dissecting scissors, tweezers and absorbent
paper. Next, they were fixed for 24 hours in paraformal-
dehyde at 4% (or other described by the technique),
transferred to phosphate buffer 10% (0.1 M pH 7.4) for
more 24 hours. After they were dehydrated in crescent
ethanol solutions at 70, 80, 90 and 95% for 30 minutes
each bath, embedded in Leica resin for 24 hours and
transferred to plastic molds which were posteriorly filled
with polymerized Leica resin. After the polymerization
of the resin, all the blocks containing the material were
sectioned at 3 μm and stained with hematoxylin and eosin.The material was examined under photomicroscope
Motic BA300.
Histochemistry
Aiming to detect the presence, frequency and distribu-
tion of polysaccharides and protein components in the
livers of the rats here studied, after the euthanasia frag-
ments of the livers were collected and subjected to the
following histochemical techniques:
Bromophenol blue technique for the detection of proteins
(according to Pearse [23])
The fragments were fixed in paraformaldehyde at 4% for
24 hours. The sections were stained with Bromophenol
blue for two hours in ambient temperature. After washed
in acetic acid at 0.5% for 5 minutes and running water for
15 minutes, the sections were quickly passed in tertiary
butyl alcohol. Next, they were air-dried, diaphanized and
mounted in Canada balsam.
PAS technique for the detection of polysaccharides
(according to Junqueira and Junqueira [24])
Fragments of the liver were fixed in aqueous Bouin for
24 hours. The slides containing the sections remained
for 10 minutes in periodic acid solution at 0.4%, quickly
washed in distilled water and subjected to Schiff reagent
for 1 h, in the dark. Posteriorly, three washes in sulfur-
ous water were performed for 3 minutes each and then
the slides were washed for 30 minutes in running water.
After dried, the slides were diaphanized in xylol and
mounted in Canada balsam.
The material was examined under MOTIC BA 300
photomicroscope, coupled with an INTEL microcomputer.
Results
Liver histology
The results obtained show the alterations in the hepatic
cells obtained from rats induced to diabetes, subjected
to physical exercises in treadmill and treatment with
aminoguanidine.
Sedentary control group (C/SD)
That results revealed the liver of the individuals from
C/SD group presents polygonal hepatocytes organized
in extended anastomosed plaques. The cytoplasm of these
cells is little acidophil, presenting reduced number of basic
components (Figure 1A). The hepatocytes present one
or two large nuclei, central, round-shaped and strongly
stained by hematoxylin. In some hepatocytes it is still
possible to observe the presence of one or more nucleoli
(Figure 1A).
There are numerous hepatic sinusoidal capillaries be-
tween the hepatocytes plates, to which walls the Kupffer
cells adhere, observed through light microscopy by the
Figure 1 Histological sections of the liver of rats. A-E. Hematoxylin
and eosin (HE) staining. A. Sedentary control (C/SD), B. Sedentary
diabetic type 1 (DB/SD), C. Trained diabetic type 1 (DB/TR), D. Sedentary
diabetic type 1 and treated with aminoguanidine (DB/SD-AG),
E. Trained diabetic type 1 and treated with aminoguanidine (DB/TR-AG).
c = hepatic sinusoidal capillaries, h = hepatocytes, Kc = Kupffer cells,
n = nucleus of hepatocytes; bv = blood vessels, arrow = nucleoli,
dotted line = interplate spaces. Scale bars: A-E = 0.02 mm.
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stained nuclei (Figure 1A).
Sedentary diabetic type 1 (DB/SD)
The alterations found in the liver of the individuals from
this group evidenced the morphophysiological modifica-
tions caused by diabetes. The hepatocytes are smaller,
as well as their nuclei. The cytoplasm is more acidophil;
i.e., with a great number of basic components (Figure 1B).
The nuclei of Kupffer cells present the same morph-
ology observed in the individuals from the sedentary
control group (Figure 1B).
Trained diabetic type 1 (DB/TR)
The individuals from this group, contrarily to what was
observed in the previous groups, presented hypertro-
phied hepatocytes. Their nuclei is also larger and with
evident nucleoli. The cytoplasm of the hepatocytes is
homogeneous and acidophil (Figure 1C). Some interplate
vacuolation is observed in these individuals, contrarily to
the previous groups (Figure 1C).
In this group, the lumen of the sinusoidal capillaries is
full of red blood cells (erythrocytes) (Figure 1C).
Sedentary diabetic type 1 and treated with aminoguanidine
(DB/SD-AG)
The liver of the individuals (DB/SD-AG) shows hepato-
cytes, with increased size in relation to those found in
the trained diabetic group (DB/TR). The nucleus of these
cells is also larger and the cytoplasm presents high
acidophili (Figure 1D).
A decrease in the presence of vacuolation is observed
(intercellular spaces) contrarily to what was observed in
the trained diabetic group (Figure 1D).
Trained diabetic type 1 and treated with aminoguanidine
(DB/TR-AG)
The livers of the trained and treated individuals (DB/TR-
AG) present significant histological alterations when com-
pared to those from control group (Figure 1E).
In this group the hepatocytes are more hypertrophied,
with shapes ranging from round to oval, consequence of
the hypertrophy (Figure 1E).
The nuclei of the hepatocytes are large and nucleoli are
evident. Acidophil granules are found in their cytoplasm.
e Nico et al. Journal of Diabetes & Metabolic Disorders 2013, 12:40 Page 5 of 9
http://www.jdmdonline.com/content/12/1/40The presence of cytoplasmic vacuoles is verified in most
hepatocytes. Some hepatocytes present great vacuolation,
mainly around the nucleus (Figure 1E).
Great vacuolation is found between the hepatocytes
plaques, as well as the presence of a great number of
erythrocytes (Figure 1E).
There is a decrease in the number of Kupffer cells (ob-
served by the presence of elongated and/or triangular);
however, atypical, pyknotic and smaller nuclei are ob-
served (Figure 1E).
Liver histochemistry
Detection of proteins–bromophenol blue technique
Sedentary control group (C/SD) The application of this
histochemical test reveals strong positivity in the cytoplasm
of the hepatocytes of the individuals (C/SD) as expected,
indicating the presence of a great number of proteins. The
nuclei of all cells (hepatocytes and Kupffer) also reacted
strongly to the test (Figure 2A). The interplate spaces of
the hepatic cells are negative to the test (Figure 2A).
Sedentary diabetic type 1 group (DB/SD) No histo-
chemical alterations were found in relation to C/SD except
for the increase in the presence of erythrocytes, strongly
stained in the light of the larger vases (Figure 2B).
Trained diabetic type 1 (DB/TR) No histochemical al-
terations were found in relation to control group except
for the increase in the presence of erythrocytes, strongly
stained in the light of the larger vases (Figure 2C).
Sedentary diabetic type 1 and treated with amino-
guanidine (DB/SD-AG) No histochemical alterations were
found in relation to control group except for the increase in
the presence of erythrocytes, strongly stained in the light of
the larger vases (Figure 2D). There is an increase in the
space between the interplates, which are negative to the test.
Trained diabetic type 1 and treated with amino-
guanidine (DB/TR-AG) Concentration of positive pro-
tein material and erythrocytes between the hepatocytes
plates is observed (Figure 2E).
Detection of neutral polysaccharides–PAS technique
Sedentary control group (C/SD) This histochemical
test reveals that the liver of the control individuals is
positive for polysaccharides, which present strongly posi-
tive fine granulation distributed throughout the cytoplasm
of the hepatocytes preferably located in the peripheral re-
gion of the cells (Figure 2F).
As this technique is not specific for the demonstration
of the nucleus, Kupffer cells (previously identified in light
microscopy by the nucleus observation) were not evidenced,
and neither were the hepatocytes nuclei (Figure 2F).Sedentary diabetic type 1 group (DB/SD) The individ-
uals from the sedentary group (DB/SD) present hepatocytes
which react weakly to the test, or even do not react, dem-
onstrating the reduction in the number of polysaccharides
in the cytoplasm. Only in some regions of the hepatic par-
enchyma the presence of strongly positive rough granula-
tion is observed. (Figure 2G).
Trained diabetic type 1 group (DB/TR) The liver of
the individuals subjected to the training presented an in-
crease in the intensity of positive staining for polysaccha-
rides with rougher granulation: concentrating preferably in
some parts of the cell (periphery of the cells) (Figure 2H).
The application of this histochemical test also shows
variation in the intensity of the reaction depending on the
region of the organ. In the regions next to the centri-
lobular veins weak positivity to the test is observed, and in
farther ones strongly positive fine granulation is observed
(Figure 2H).
Sedentary diabetic type 1 and treated with amino-
guanidine (DB/SD-AG) The hepatocytes of the individ-
uals from this group show a similar reaction to the one
observed in the sedentary diabetic group (DB/SD); i.e.,
weak cytoplasmic positivity and strongly positive rough
granulation in some regions (Figure 2I).
Trained diabetic type 1 and treated with amino-
guanidine (DB/TR-AG) The liver of the trained and
treated individuals (DB/TR-AG) present the same distri-
bution of polysaccharides observed in the liver of indi-
viduals from DB/TR group: with positive polysaccharide
granulations distributed in great number throughout the
cytoplasm of the hepatocytes (Figure 2J).
The results obtained are represented in Table 1.
Discussion
The hyperglycemia (high level of glucose in the blood),
is a characteristic found in individuals who suffer from
DM types 1 and 2, being considered the primary causing
factor of the micro and macrovascular complications in
these individuals. Such complications cause chronic de-
generations such as: cardiopathy, nephropathy, retinop-
athy and neuropathy, which affect the life quality of the
individuals [25]. Among the vias which lead to the vascular
lesions associated to DM, the one of endogenous formation
of advanced glycation products, also called (AGEs), has
been currently considered the most important [26].
The AGEs are highly reactive and cause damage to the
cells, once they modify the intracellular structures, due to
the interaction of AGEs with the proteins of the extracellular
matrix (modifying the cellular signalization) and also
modify the blood proteins or lipids. Thus, the AGEs
react with several compounds present in the organisms
Figure 2 (See legend on next page.)
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Figure 2 Histological sections of the liver of rats. A-E. Bromophenol blue staining to detect proteins. A. Sedentary control (C/SD), B. Sedentary
diabetic type 1 (DB/SD), C. Trained diabetic type 1 (DB/TR), D. Sedentary diabetic type 1 and treated with aminoguanidine (DB/SD-AG), E. Trained
diabetic type 1 and treated with aminoguanidine (DB/TR-AG). F-J. PAS staining to detect polysaccharides. F. Sedentary control (C/SD), G. Sedentary
diabetic type 1 (DB/SD), H. Trained diabetic type 1 (DB/TR), I. Sedentary diabetic type 1 and treated with aminoguanidine (DB/SD-AG), J. Trained
diabetic type 1 and treated with aminoguanidine (DB/TR-AG). c = hepatic sinusoidal capillaries, h = hepatocytes, bv = blood vessels,
dotted line = interplate spaces. Scale bars: A-E = 0.02 mm.
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functional capability, causing oxidative stress, morphofunc-
tional alterations and increase in the inflammatory pro-
cesses [25,27,28].
Pimagedine is a compound which prevents the forma-
tion of AGEs [14], and also reacts as an antioxidant agent
preventing the formation of ROS (reactive oxygen species)
and the lipid peroxidation in the cells and tissues [29].
It was observed in this study that in the individuals
from the sedentary control group (C/SD), the liver showed
a well-known and morphology and histology described in
the literature on mammals [30-32]; i.e., hepatic paren-
chyma composed by hepatocytes plates which anastomose
permeated by sinusoidal capillaries and Kupffer cells (hep-
atic macrophages).
Morphological alterations were found in the livers of
sedentary diabetic individuals, (DB/SD) probably caused
by diabetes, such as the presence of smaller hepatocytes,
suggesting the decrease of the cellular hepatic metabol-
ism, once the glucose available in the blood could not be
absorbed by the cell due to the decrease or absence of
insulin, corroborating Remédio [33], who studied Wistar
diabetic rats.
In the diabetic individuals subjected to training (DB/
TR), the hepatocytes and their nuclei underwent a process
of hypertrophy which increased their size when compared
with the individuals from the control group (C/SD) and
sedentary diabetic (DB/SD). According to Rhodes et al.
[34] and Teh et al. [35], the cellular hypertrophy (gradual
increase in the cytoplasmic area of the hepatocytes) would
occur due to several factors, among them the occurrence
of the metabolic overload imposed to the cell, which prob-
ably occurred to the individuals in this study, justifying
the swelling observed in the hepatocytes of the trainedTable 1 Results of the histochemical tests applied on the live
Control (C/SD), Sedentary Diabetic (DB/SD), Trained Diabetic
(DB/SD-AG), Trained Diabetic Treated with Aminoguanidine (
Histochemical tests C/SD DB/SD
NH NK EI LV NH NK EI LV NH
Bromophenol blue + +++ + + + +++ + ++ +
PAS - - - - - - - - -
(+++) strongly positive, (++) mediumly positive, (+) weakly positive, (−) negative
(LV) vases lumen.individuals’ livers. The same situation was also observed
for the rats from the sedentary diabetic group treated with
aminoguanidine (DB/SD-AG).
In the liver of the individuals from the trained diabetic
type 1 treated with aminoguanidine (DB/TR-AG) the hyper-
trophy of the hepatic cells persisted and here the largest
hepatocytes were observed, with an increase in the inter-
plates space, suggesting a positive effect and somatization
of the training and treatment with aminoguanidine in
groups (DB/TR) and (DB/SD-AG), which lead to the most
relevant alterations observed in relation to the sedentary
control group.
In this study, the use of histochemical techniques per-
mitted the observation of the distribution of proteins
and polysaccharides in the liver of the individuals from
all the groups studied. Thus, the presence of proteins in
the liver of the individuals from the sedentary control
group (C/SD) was significant and demonstrated by the
strong reaction to Bromophenol blue in the cytoplasm
of the hepatocytes and cellular nucleus. Among the rats
from the diabetic groups, greater alterations were not
observed; i.e., in all the groups a similar distribution to
the one found in the livers from sedentary control group
was detected (C/SD), corroborating data by Bond [36],
on diabetic rats. However, the results oppose those by
Bahnak and Gold [37] who reported that the synthesis of
proteins in diabetic individuals would be reduced, due to
the high protein catabolism (breakdown of protein to
obtain energy in the absence of carbohydrate).
The polysaccharides, which play an important role in
the hepatocytes once they are stored in form of glyco-
gen, were also studied here. In the liver of individuals
from the sedentary control group (C/SD), the polysac-
charides were observed with strongly PAS positive finer of rats subjected to the following situations: Sedentary
(DB/TR), Sedentary Diabetic Treated with Aminoguanidine
DB/SD-TR)
DB/TR DB/SD-AG DB/TR/AG
NK EI LV NH NK EI LV NH NK EI LV
+++ ++ ++ + +++ + ++ + +++ ++ ++
- - - - - - - - - - -
, (NH) hepatocyte nucleus, (NK) Kupffer cell nucleus, (EI) interplate space,
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the liver has the function to intermediate the conversion
of energy from the food and supply extra-hepatic tissues,
it is suggested that it would be capturing the glucose
from the digestion and transforming it in glycogen to be
stored in the hepatocyte [38].
In the sedentary diabetic group (DB/SD), a reduction in
the staining for polysaccharides in most part of the hepato-
cytes’ cytoplasm was evident, corroborating Vallance-Owen
[39]; Whitton and Hems [40], who also reported that the
hyperglycemia in the diabetic individuals would be associ-
ated to the decrease of hepatic glycogen, due to a fault in
the process of retaining glycogen in the liver. The lack of
insulin and excess of glucagon, typical conditions of dia-
betic individuals, would affect the performance of the
glycogenolytic and glycogenic enzymes, which would be
contributing to lessen the storage of glycogen by the liver
[41]. Thus, data obtained in this study suggest that in
the diabetic individuals, the synthesis and the action of
glycogenolytic and glycogenic enzymes would be impaired,
which would decrease or prevent the synthesis of glycogen
or increase in its breakdown (lysis) in the liver. This glyco-
gen breakdown in diabetics would be a facilitator for the
release of a greater number of polysaccharides to the
blood, increasing the hyperglycemia and causing even
more damage to the liver and the organism as a whole.
In the rats from the trained diabetic group (DB/TR),
more intense staining for polysaccharides in the cyto-
plasm of hepatocytes was observed when compared with
the individuals from the sedentary diabetic group DB/SD,
suggesting that the regular and periodic physical activity
would improve the process of hepatic glycogen accumula-
tion (re-synthesis) [42,43]. In the liver of trained individ-
uals, probably by the lower production of glucose with
consequent reduction of hyperglycemia.
Still in the liver of the individuals from this group a
differentiated staining for polysaccharides was verified,
varying according to the proximity to the larger vases
(center-lobular veins). The hepatocytes located around
them reacted weakly to PAS, suggesting that they would
be the first to provide glycogen during the physical exer-
cise, decreasing their reserve. Similar results were also
found by Ferranini [44] in diabetic rats.
In the liver of the individuals from the sedentary dia-
betic group treated with aminoguanidine (DB/SD-AG),
similar alterations to those from the sedentary diabetic
group were observed (DB/SD): hepatocytes weakly posi-
tive to PAS indicating that the aminoguanidine did not
interfere in the metabolism of polysaccharides which were
stored in the liver of diabetic individuals.
In the trained and treated diabetic individuals (DB/TR-
AG) polysaccharide staining and similar distribution to the
one found in the liver of individuals from DB/TR group
was detected, which would be justified by the interferenceof physical training and the absence of aminoguanidine
(already confirmed in the previous group), confirming the
benefits of moderate physical exercises for diabetic indi-
viduals, once there is an increase in the accumulation of
hepatic glycogen. According to Guyton [8] the absence of
insulin would impair the transportation of glucose to the
interior of the cells, specially the muscucular, adipose
and hepatic.
Conclusions
The results obtained in this study suggest that the
aminoguanidine is not hepatotoxic when used in the dos-
age of 1 g/L for the treatment of diabetes complications
and also confirmed that moderate physical exercises re-
duced the damages caused by diabetes (increasing the
utilization of glucose by muscular cells) without the use
of insulin.
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